BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Avrio Biopharmaceuticals Receives ISO 13485:2003 Certification for Medical Device Manufacturing


10/29/2010 6:58:29 AM

IRVINE, Calif., Oct. 28 /PRNewswire/ -- Avrio Biopharmaceuticals, LLC, a premier pharmaceutical manufacturing and development organization is pleased to announce it received the certification for ISO 13485:2003. This certification is a testament to the stringent quality systems and ever expanding service offerings here at Avrio. With this certification, Avrio achieves and exceeds the requirements set forth in ISO 13485 for a comprehensive management system for the design and manufacture of medical devices.

"Based on the needs and requests of our clients, Avrio has grown tremendously as a company in order to meet our client's expectations for ISO certification.," said Yvonne Verburgt, Vice President of Business Development. "Being ISO 13485 certified validates our facility design, quality systems, and procedures for the design and manufacturing of medical devices."

The certification for ISO 13485:2003 assures that Avrio meets the regulatory requirements of 21 CFR 820 Quality System Regulation for Medical Devices sold in the United States.

"The goal at Avrio is to continue to grow with our current and prospective clients, as well as the industry as a whole," says Yvonne Verburgt. "How you successfully meet your clients' needs is what really sets you a part from the rest. We are pleased to have our expertise validated in this arena and look forward to many further expansions of our service capabilities."

To learn more about how Avrio is growing to meet client requirements for high quality manufacturing and development services, visit www.avriobiopharma.com or call: 866-98-AVRIO.

About Avrio Biopharmaceuticals, LLC

Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract manufacturing lab providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, aseptic filling, scale-up studies, packaging and labeling, stability testing and complete analytical CMC testing. Learn more at www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).

SOURCE Avrio Biopharmaceuticals, LLC



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES